Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Split dose cytotoxic experiments with misonidazole.

I J Stratford

    British Journal of Cancer
    |July 1, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Misonidazole (1-(2-nitroimidazol-1-yl)-3-methoxy-2-propanol) is most toxic to mammalian cells under hypoxic conditions. Oxygen can repair misonidazole-induced lethal damage in a time- and concentration-dependent manner.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Emerging opportunities for the combination of molecularly targeted drugs with radiotherapy.

    Clinical oncology (Royal College of Radiologists (Great Britain))·2014
    Same author

    Electron-affinic sensitization VII. A correlation between structures, one-electron reduction potentials, and efficiencies of nitroimidazoles as hypoxic cell radiosensitizers. 1976.

    Radiation research·2012
    Same author

    Guidelines for preclinical and early phase clinical assessment of novel radiosensitisers.

    British journal of cancer·2011
    Same author

    The hypoxia-selective cytotoxin NLCQ-1 (NSC 709257) controls metastatic disease when used as an adjuvant to radiotherapy.

    British journal of cancer·2010
    Same author

    Guidelines for the welfare and use of animals in cancer research.

    British journal of cancer·2010
    Same author

    Radiotherapy research priorities for the UK.

    Clinical oncology (Royal College of Radiologists (Great Britain))·2010
    Same journal

    The concept of functional cure in advanced/metastatic melanoma treated with combined nivolumab and ipilimumab or nivolumab alone.

    British journal of cancer·2026
    Same journal

    Efficacy and safety of a novel oral anti-vasculogenic mimicry agent, CVM-1118, in advanced well-differentiated neuroendocrine tumors: a Phase IIa trial.

    British journal of cancer·2026
    Same journal

    Altretamine induces ferroptosis in small cell lung cancer by promoting epigenetic silencing and lysosomal degradation of GPX4.

    British journal of cancer·2026
    Same journal

    Revisiting retinoic acid in AML therapy: mechanisms of action and rational combination strategies.

    British journal of cancer·2026
    Same journal

    De novo cancer-related mortality after solid organ transplantation in England: the EpCOT study.

    British journal of cancer·2026
    Same journal

    Planetary Health Diet Index and breast cancer risk.

    British journal of cancer·2026
    See all related articles

    Area of Science:

    • Cell Biology
    • Pharmacology
    • Biochemistry

    Background:

    • Misonidazole is a nitroimidazole compound investigated for its potential as a radiosensitizer.
    • Understanding the mechanisms of misonidazole toxicity is crucial for its therapeutic applications.

    Purpose of the Study:

    • To determine the in vitro toxicity of misonidazole on mammalian cells.
    • To investigate the influence of oxygen tension on misonidazole toxicity.
    • To explore the role of oxygen in repairing misonidazole-induced cellular damage.

    Main Methods:

    • In vitro exposure of mammalian cells to misonidazole under varying oxygen tensions.
    • Split-dose experiments to assess the repair of lethal damage.
    • Evaluation of hyperthermia effects on damage repair.

    Related Experiment Videos

    Main Results:

    • Misonidazole exhibits maximal toxicity under hypoxic conditions (O2 tension < 10 Parts/10(6) O2).
    • Oxygen exposure can repair misonidazole-induced lethal damage.
    • The magnitude of oxygen-mediated repair is dependent on time and oxygen concentration, with peak repair observed after 2 hours in air at 37°C.
    • Modest hyperthermia (41°C) does not inhibit this oxygen-dependent repair.

    Conclusions:

    • Misonidazole toxicity is significantly influenced by oxygen levels.
    • Oxygen plays a critical role in mitigating misonidazole-induced cellular damage.
    • The repair mechanism differs from that of radiation damage, as it is not inhibited by hyperthermia.